Omaha, NE Strecks A1c-Cellular® is now assayed for the Ortho-Clinical Diagnostics VITROS® 4600.
A1c-Cellular is the first HbA1c control on the market with intact red blood cells. A1c-Cellular tests the accuracy and linear reportable range of the HbA1c parameter. It tests the entire HbA1c procedure, including the lysing of the red blood cell a step omitted with other controls.
A1c-Cellular is also assayed for Abbott ARCHITECT® c Systems/ARCHITECT® i/Integrated c i Systems, ARKRAY Menarini ADAMS A1c HA-8160, Beckman Coulter® UniCel® DxC 600/800, Bio-Rad® D-10/Variant II/Variant II Turbo, Siemens Dimension Series, VITROS® 5,1 FS/5600, Roche cobas INTEGRA®/6000/c 311 and Tosoh G7/G8.
A1c-Cellular is available in plastic cap-pierceable vials which allow autosampling for HbA1c analyzers with such capabilities. The product is a ready-to-use liquid control appropriate for immunoassay and ionic exchange HPLC methodologies, with 180-day closed-vial stability and 30-day open-vial stability.
Streck also offers A1c-Cellular® Linearity, the only commercially available HbA1c linearity/calibration verification material with intact red blood cells. A1c-Cellular Linearity is available in a 5-level set with plastic cap-piercable vials which allow autosampling for HbA1c analyzers with such capabilities. It has 105-day closed-vial stability and 7-day open-vial stability.
About Streck, Inc.
Streck is an industry leader in the development and manufacturing of products for clinical and research laboratories. The companys pursuit of innovative solutions has produced an extensive list of patented products. Strecks core technology is cell stabilization; product lines support the fields of hematology, immunology and molecular diagnostics. For more information, visit www.streck.com.